These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35552566)

  • 21. Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient.
    Adabala M; Jhaveri KD; Gitman M
    Nephrol Dial Transplant; 2010 Oct; 25(10):3439-42. PubMed ID: 20610525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight-based carbohydrate treatment of hypoglycaemia in people with Type 1 diabetes using insulin pump therapy: a randomized crossover clinical trial.
    McTavish L; Corley B; Weatherall M; Wiltshire E; Krebs JD
    Diabet Med; 2018 Mar; 35(3):339-346. PubMed ID: 29285796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study.
    Vlasselaers D; Milants I; Desmet L; Wouters PJ; Vanhorebeek I; van den Heuvel I; Mesotten D; Casaer MP; Meyfroidt G; Ingels C; Muller J; Van Cromphaut S; Schetz M; Van den Berghe G
    Lancet; 2009 Feb; 373(9663):547-56. PubMed ID: 19176240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
    Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
    Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia.
    Heller S; Mathieu C; Kapur R; Wolden ML; Zinman B
    Diabet Med; 2016 Apr; 33(4):478-87. PubMed ID: 26484727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of dextrose 50 bolus versus dextrose 10 infusion in the management of hyperkalemia in the ED.
    Yang I; Smalley S; Ahuja T; Merchan C; Smith SW; Papadopoulos J
    Am J Emerg Med; 2020 Mar; 38(3):598-602. PubMed ID: 31837905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of sulfonylurea and insulin overdose.
    Klein-Schwartz W; Stassinos GL; Isbister GK
    Br J Clin Pharmacol; 2016 Mar; 81(3):496-504. PubMed ID: 26551662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?
    Heller SR; Amiel SA; Evans ML; Kong MF; Macdonald IA; Peacey SR
    Diabetes Obes Metab; 2002 Mar; 4(2):106-12. PubMed ID: 11940107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design.
    Agesen RM; Alibegovic AC; Andersen HU; Beck-Nielsen H; Gustenhoff P; Hansen TK; Hedetoft C; Jensen T; Juhl CB; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    BMC Endocr Disord; 2019 Jul; 19(1):78. PubMed ID: 31337371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hyperkalaemia.
    Maxwell AP; Linden K; O'Donnell S; Hamilton PK; McVeigh GE
    J R Coll Physicians Edinb; 2013; 43(3):246-51. PubMed ID: 24087806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials.
    Lu J; Tang L; Meng H; Zhao J; Liang Y
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3169. PubMed ID: 30974510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: A phase 3 randomized crossover study.
    Matsuhisa M; Takita Y; Nasu R; Nagai Y; Ohwaki K; Nagashima H
    Diabetes Obes Metab; 2020 Jul; 22(7):1167-1175. PubMed ID: 32115879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
    Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
    Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for preventing critical illness polyneuropathy and critical illness myopathy.
    Hermans G; De Jonghe B; Bruyninckx F; Van den Berghe G
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD006832. PubMed ID: 24477672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for hypoglycaemia in non-critical hospitalised diabetic patients.
    Valero Garzón D; Forero Saldarriaga S; Robayo Batancourt AM; Puerta Rojas JD; Aranguren Pardo V; Fajardo Latorre LP; Ibañez Pinilla M
    Endocrinol Diabetes Nutr (Engl Ed); 2024 May; 71(5):194-201. PubMed ID: 38852007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current practice of hypoglycemia management in the ED.
    Bilhimer MH; Treu CN; Acquisto NM
    Am J Emerg Med; 2017 Jan; 35(1):87-91. PubMed ID: 27832978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.